Clinical Trials Directory

Trials / Unknown

UnknownNCT06032819

Differentiating Between Brain Hemorrhage and Contrast

Artificial Intelligence for Differentiating Between Brain Hemorrhage and Contrast Extravasation After Mechanical Revascularization in Acute Ischemic Stroke

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to use artificial intelligence to differentiate cerebral hemorrhage from contrast agent extravasation after mechanical revascularization in ischemic stroke. The main question it aims to answer is: Whether artificial intelligence can help differentiate brain hemorrhage from contrast agent extravasation. Patients with intracranial high-density lesions on CT scans within 24h after mechanical revascularization will be included. Expected to enroll 500 patients. The type of high-density lesion is determined according to dual-energy CT images or follow-up images. Patients will be divided into training group, validation and testing groups by stratified random sampling (6:2:2). After the images and the image labels are obtained, deep learning artificial intelligence will be used to learn the image characteristics and establish a diagnostic model, and the model performance and generalization ability will be evaluated.

Conditions

Timeline

Start date
2023-09-01
Primary completion
2024-07-01
Completion
2024-12-01
First posted
2023-09-13
Last updated
2023-09-13

Source: ClinicalTrials.gov record NCT06032819. Inclusion in this directory is not an endorsement.

Differentiating Between Brain Hemorrhage and Contrast (NCT06032819) · Clinical Trials Directory